2026-06-03 openai
GPT-Rosalind has AI critique the kind of evidence the FDA itself split over
OpenAI anchors scientific AI to workflows with LifeSciBench, then picks an FDA surrogate-endpoint case that mirrors Elevidys — exposing the real test for domain models: will they say the evidence isn't enough, exactly where the experts didn't agree?
Read analysis